Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorio sanderson s.a. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios arsal, s.a. de c.v. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vitalis s.a.c.i. - neostigmina metilsulfato - neostigmina metilsulfato....0.5 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios stein, s.a. - rivastigmina base - rivastigmina base....18mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

laboratorios stein, s.a. - rivastigmina base - rivastigmina base....9mg

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - rifampicin, quantity: 300 mg - capsule, hard - excipient ingredients: purified talc; gelatin; purified water; ascorbic acid; magnesium stearate; brilliant blue fcf; colloidal anhydrous silica; sodium lauryl sulfate; titanium dioxide; erythrosine; lactose monohydrate - indications as at 5 december 2001 : tuberculosis. in the initial treatment and in retreatment of patients with tuberculosis, rifampicin must be used in conjunction with at least one other antituberculosis drug. leprosy - in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the non-infectious state which may be expected to occur in three to four months of treatment. - as an alternative drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other anti-leprosy drugs. - as an alternative drug in all those patients having true drug allergy to the more commonly used anti-leprosy drugs.,meningococcal disease prophylaxis of meningococcal disease in close contacts of known cases and in carriers (rifampicin is not indicated for the treatment of meningococcal infections).,haemophilus influenzae prophylaxis of household contacts of patients with haemophilus influenzae type b.,buruli ulcer for the treatment of myc

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - rifampicin, quantity: 150 mg - capsule, hard - excipient ingredients: ascorbic acid; magnesium stearate; iron oxide red; colloidal anhydrous silica; purified water; lactose monohydrate; brilliant blue fcf; purified talc; iron oxide yellow; erythrosine; gelatin; sodium lauryl sulfate; titanium dioxide - indications as at 5 december 2001 : tuberculosis. in the initial treatment and in retreatment of patients with tuberculosis, rifampicin must be used in conjunction with at least one other antituberculosis drug. leprosy - in the management of lepromatous leprosy and dimorphous leprosy to effect speedy conversion of the infectious state to the non-infectious state which may be expected to occur in three to four months of treatment. - as an alternative drug in lepromatous, dimorphous, indeterminate and tuberculoid leprosy resistant to sulfones and other anti-leprosy drugs. - as an alternative drug in all those patients having true drug allergy to the more commonly used anti-leprosy drugs.,meningococcal disease prophylaxis of meningococcal disease in close contacts of known cases and in carriers (rifampicin is not indicated for the treatment of meningococcal infections).,haemophilus influenzae prophylaxis of household contacts of patients with haemophilus influenzae type b.,buruli ulcer for the treatment of myc

United States - English - NLM (National Library of Medicine)

agri laboratories, ltd. - oxytetracycline (unii: x20i9en955) (oxytetracycline anhydrous - unii:slf0d9077s) - oxytetracycline 200 mg in 1 ml - agrimycin 200 is intended for use in the treatment of the following diseases in beef cattle; calves, including preruminating (veal) calves; and swine when due to oxytetracycline-susceptible organisms: cattle : agrimycin 200 is indicated in the treatment of pneumonia and shipping fever complex associated with pasteurella spp. and haemophilus spp; infectious bovine keratoconjunctivitis (pinkeye) caused by moraxella bovis ; foot rot and diphtheria caused by fusobaterium necrophorum ; bacterial enteritis (scours) caused by escherichia coli ; wooden tongue caused by actinobacillus ligniereslii ; leptospirosis caused by leptospira pomona ; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline. swine : agrimycin 200 is indicated in the treatment of bacterial enteritis (scours, colibacillosis) caused by escherichia coli ; pneumonia caused by pasteurella multocida ; and leptospirosis caused by leptospira pomona . in sows, agrimycin

United States - English - NLM (National Library of Medicine)

mwi veterinary supply, inc. - oxytetracycline (unii: x20i9en955) (oxytetracycline anhydrous - unii:slf0d9077s) - vetrimycin 200 is intended for use in the treatment of the following diseases in beef cattle; calves, including preruminating (veal) calves; and swine when due to oxytetracycline-susceptible organisms: cattle : vetrimycin 200 is indicated in the treatment of pneumonia and shipping fever complex associated with pasteurella  spp. and haemophilus  spp; infectious bovine keratoconjunctivitis (pinkeye) caused by moraxella bovis ; foot rot and diphtheria caused by fusobaterium necrophorum ; bacterial enteritis (scours) caused by escherichia coli ; wooden tongue caused by actinobacillus ligniereslii ; leptospirosis caused by leptospira pomona ; and wound infections and acute metritis caused by strains of staphylococci and streptococci organisms sensitive to oxytetracycline.  swine : vetrimycin 200 is indicated in the treatment of bacterial enteritis (scours, colibacillosis) caused by escherichia coli ; pneumonia caused by pasteurella multocida ; and leptospirosis caused by leptospira pomona . in sows, vetrimycin 200

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

asofarma s.a.i. y c. - rivastigmina base - rivastigmina base....6.84mg